London Co. of Virginia Sells 857,435 Shares of Avantor, Inc. $AVTR

by · The Cerbat Gem

London Co. of Virginia reduced its stake in Avantor, Inc. (NYSE:AVTR – Free Report) by 6.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 11,936,522 shares of the company’s stock after selling 857,435 shares during the period. London Co. of Virginia’s holdings in Avantor were worth $136,793,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. Private Trust Co. NA increased its holdings in Avantor by 46.2% in the 4th quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock valued at $32,000 after acquiring an additional 875 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Avantor by 28.1% in the 3rd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,123 shares of the company’s stock valued at $49,000 after acquiring an additional 905 shares during the last quarter. Osaic Holdings Inc. increased its holdings in Avantor by 60.9% in the 2nd quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock valued at $38,000 after acquiring an additional 1,064 shares during the last quarter. UMB Bank n.a. increased its holdings in Avantor by 17.6% in the 4th quarter. UMB Bank n.a. now owns 7,371 shares of the company’s stock valued at $84,000 after acquiring an additional 1,101 shares during the last quarter. Finally, EverSource Wealth Advisors LLC increased its holdings in Avantor by 119.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock valued at $29,000 after acquiring an additional 1,189 shares during the last quarter. 95.08% of the stock is currently owned by institutional investors.

Insider Transactions at Avantor

In other news, Director Gregory T. Lucier purchased 10,000 shares of the company’s stock in a transaction that occurred on Friday, May 8th. The stock was purchased at an average cost of $8.32 per share, with a total value of $83,200.00. Following the purchase, the director owned 60,000 shares in the company, valued at approximately $499,200. This trade represents a 20.00% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Simon Dingemans purchased 25,000 shares of the company’s stock in a transaction that occurred on Friday, May 1st. The shares were purchased at an average cost of $8.14 per share, with a total value of $203,500.00. Following the completion of the purchase, the director owned 25,000 shares in the company, valued at $203,500. This trade represents a ∞ increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders own 0.28% of the company’s stock.

Avantor Stock Performance

Avantor stock opened at $9.57 on Wednesday. The company’s 50-day moving average price is $8.45 and its 200-day moving average price is $9.59. Avantor, Inc. has a twelve month low of $7.26 and a twelve month high of $15.93. The company has a quick ratio of 1.17, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The company has a market cap of $6.54 billion, a PE ratio of -11.82, a price-to-earnings-growth ratio of 5.63 and a beta of 0.97.

Avantor (NYSE:AVTR – Get Free Report) last posted its earnings results on Wednesday, April 29th. The company reported $0.17 earnings per share for the quarter, topping analysts’ consensus estimates of $0.16 by $0.01. Avantor had a negative net margin of 8.42% and a positive return on equity of 9.95%. The firm had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.54 billion. During the same period in the previous year, the firm posted $0.23 EPS. The business’s quarterly revenue was up .0% on a year-over-year basis. On average, equities research analysts forecast that Avantor, Inc. will post 0.79 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

AVTR has been the topic of a number of research reports. Wall Street Zen downgraded shares of Avantor from a “buy” rating to a “hold” rating in a report on Saturday, May 30th. Royal Bank Of Canada assumed coverage on shares of Avantor in a report on Thursday, May 14th. They issued a “sector perform” rating and a $9.00 price target on the stock. Wolfe Research downgraded shares of Avantor to an “underperform” rating and set a $7.00 target price on the stock. in a report on Monday, June 1st. Barclays reduced their target price on shares of Avantor from $8.50 to $7.00 and set an “underweight” rating on the stock in a report on Tuesday, April 14th. Finally, Citigroup reduced their target price on shares of Avantor from $11.00 to $9.00 and set a “neutral” rating on the stock in a report on Thursday, April 30th. Two equities research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Reduce” and an average target price of $10.57.

Read Our Latest Analysis on AVTR

About Avantor

(Free Report)

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.

Featured Articles

Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).